ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $419K of Zentalis Pharmaceuticals, Inc.
Sold$419,241
$41.92Price
10,000Shares
−3%Stake
What ZNTL did after the filing
- The stock from Wed, Mar 16 close, $43.47
- −40.6%
- S&P 500, same days
- −1.5%
Measured over 30 trading days, to the Apr 28 close.
Traded Tue, Mar 15. Filed Wed, Mar 16, 1:18 PM ET, during the session. Returns use the Mar 16 close and the Apr 28 close. Not investment advice.